TP53 and neoplasm: However, when combined together, Nutlin-3 and PK11195 showed a synergic/additive effect on cell viability inhibition, comparable to that produced by treatment with 1 or 7 (Figure 8D), confirming that the simultaneous TSPO-p53 activation could be useful in blocking tumor cell proliferation.